News

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
"These data confirm Zepbound as a leading treatment option for people living with obesity and equip healthcare ...
Novo Nordisk (NYSE: NVO) has entered into a collaboration and licensing agreement with U.S.-based biotech firm Septerna ...
Zepbound is also prescribed to treat moderate to severe obstructive sleep apnea in adults with obesity ... such as your treatment plan and the pharmacy you use. Here are a few things to consider ...
President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...